APPLIED GENETIC TECHNOLOGIES CORP·4

Dec 1, 9:15 AM ET

Lieber Jonathan I 4

4 · APPLIED GENETIC TECHNOLOGIES CORP · Filed Dec 1, 2022

Insider Transaction Report

Form 4
Period: 2022-11-30
Lieber Jonathan I
Chief Financial Officer
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2022-11-30202,0000 total
    Exercise: $3.30Exp: 2031-09-20Common Stock (202,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2022-11-30154,7000 total
    Exercise: $0.40Exp: 2032-08-21Common Stock (154,700 underlying)
Footnotes (1)
  • [F1]At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES